These statements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. These results are not typical. Individual results may vary.

 

Articles and information on this website may only be copied, reprinted, or redistributed with written permission. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice, it is intended as a sharing of knowledge and information. We will attempt to keep all objectionable messages off this site; however, it is impossible to review all messages immediately. All messages expressed on NAD Treatment Center Forum or Blog, including comments posted to Blog entries, represent the views of the author exclusively and we are not responsible for the content of any message.

I

  • Facebook - White Circle
  • Twitter - White Circle
  • Google+ - White Circle
  • White YouTube Icon

Our Practice

Conditions

Resources

A New Study on Brain Injuries

June 05, 2016

Thorne Research, a global healthcare company dedicated to improving the health and wellness of people through science and technology, announced a new clinical study to assess the effect of Nicotinamide Riboside (NR) on brain NAD+ in college football players.

 

The study is scheduled to begin in May 2016 in collaboration with The Mayo Clinic and University of Minnesota Clinical and Translational Science Institute. We’ll continue to provide updates on the study but in the meantime, you can learn more here.

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
Related Posts